Mechanical thrombectomy devices for the management of pulmonary embolism
- PMID: 39749259
- PMCID: PMC11695062
- DOI: 10.1016/j.jvsvi.2024.100053
Mechanical thrombectomy devices for the management of pulmonary embolism
Abstract
Objective: The aim of this study was to review the most commonly used percutaneous mechanical thrombectomy devices for the treatment of pulmonary embolism today.
Methods: A thorough search of the existing literature was conducted on commonly used percutaneous mechanical thrombectomy devices, most notably Inari Flowtriever, Penumbra's Indigo Aspiration, and Alphavac. Reported qualitative and quantitative information was abstracted and descriptively reviewed to ascertain the clinical utility and effectiveness of these devices.
Results: Inari Flowtriever is one of the most frequently utilized thrombectomy devices with the most substantive industry-sponsored trial data. Penumbra's Indigo Aspiration is one of the up-and-coming devices that presents certain caveats in addition to the commonly utilized features of a percutaneous mechanical thrombectomy device, making it a viable alternative. Other newer devices such as Alphavac still lack substantial data, with some other lesser-known devices sporadically used and showing limited, primarily anecdotal evidence.
Conclusions: Each device has its positives and negatives. Data are growing on the clinical utility of these devices as their use is becoming more common. However, the long-term durability and overall cost-effectiveness remains to be determined. (JVS-Vascular Insights 2024;2:100053.).
Keywords: Alphavac; Inari; Mechanical thrombectomy; Penumbra; Submassive pulmonary embolism.
Conflict of interest statement
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
Figures



References
-
- Pineda LA, Hathwar VS, Grant BJ. Clinical suspicion of fatal pulmonary embolism. Chest. 2001;120:791–795. - PubMed
-
- Jaff MR, McMurtry MS, Archer SL, et al. American Heart Association Council on cardiopulmonary, critical care, perioperative and resuscitation; American Heart Association Council on peripheral vascular disease; American Heart Association Council on arteriosclerosis, thrombosis and vascular biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–1830. - PubMed
-
- Avgerinos ED, Abou Ali A, Toma C, et al. Catheter-directed thrombolysis versus suction thrombectomy in the management of acute pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2019;7:623–628. - PubMed
-
- Avgerinos ED, Jaber W, Lacomis J, et al., SUNSET sPE collaborators. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the SUNSET sPE trial. JACC Cardiovasc Interv. 2021;14:1364–1373. Erratum in: JACC Cardiovasc Interv. 2021 Oct 11;14(19):2194. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources